MNKD : Summary for MannKind Corporation - Yahoo Finance

U.S. Markets open in 6 hrs 9 mins

MannKind Corporation (MNKD)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.52+0.01 (+1.69%)
At close: 4:00PM EST
People also watch
OREXARNAGALEKERXARIA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.51
Open0.52
Bid0.48 x 15100
Ask0.50 x 400
Day's Range0.51 - 0.54
52 Week Range0.41 - 2.24
Volume1,798,324
Avg. Volume5,149,629
Market Cap250.23M
Beta3.25
PE Ratio (TTM)-1.13
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Barrons.com13 hours ago

    Can MannKind Be Saved?

    Hopes were high for MannKind (MNKD) when its inhaled insulin Afrezza was approved by the FDA more than two years ago. At the time, Barron's warned that it was time to dump MannKind's shares, something that now seems prescient, as its shares have since tumbled 95%. MannKind found a partner in Sanofi (SNY), only to get dumped in early 2016, and has since been forced to sell property to raise cash.

  • GlobeNewswire7 days ago

    MannKind Receives $16.7 Million From Sale of Valencia Property 

    VALENCIA, Calif., Feb. 21, 2017-- MannKind Corporation today confirmed that it received $16.7 million on February 17, 2017, upon closing the sale of real estate owned by the Company in Valencia, California, ...

  • 24/7 Wall St.18 days ago

    The 6 Most Shorted Nasdaq Stocks

    Judging by the most shorted stocks traded on the Nasdaq in late January, those short sellers who remained active continued to be cautious.